These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33427545)

  • 1. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
    Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
    Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
    Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
    Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of Colorectal Cancer Screening in Detecting Earlier-Stage Disease-A Nationwide Cohort Study in Denmark.
    Larsen MB; Njor S; Ingeholm P; Andersen B
    Gastroenterology; 2018 Jul; 155(1):99-106. PubMed ID: 29626451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 6. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
    Larsen PT; Jørgensen SF; Njor SH
    BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colorectal cancer mortality after randomized implementation of FIT-based screening - a nationwide cohort study.
    Njor SH; Larsen MB; Søborg B; Andersen B
    J Med Screen; 2022 Dec; 29(4):241-248. PubMed ID: 35635233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nationwide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study.
    Olesen TB; Jensen H; Møller H; Jensen JW; Andersen B; Rasmussen M
    Elife; 2023 Jan; 12():. PubMed ID: 36695411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
    van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
    Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence and characteristics of faecal immunochemical screen-detected cancers vs non-screen-detected cancers: Results from a Flemish colorectal cancer screening programme.
    van de Veerdonk W; Hoeck S; Peeters M; Van Hal G; Francart J; De Brabander I
    United European Gastroenterol J; 2020 Mar; 8(2):185-194. PubMed ID: 32213071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal immunochemical test after negative colonoscopy may reduce the risk of incident colorectal cancer in a population-based screening programme.
    Peng SM; Hsu WF; Wang YW; Lin LJ; Yen AM; Chen LS; Lee YC; Wu MS; Chen TH; Chiu HM
    Gut; 2021 Jul; 70(7):1318-1324. PubMed ID: 32989019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent participation in organized FIT based screening following screen-derived colonoscopy
    Bülow Therkildsen S; Larsen PT; Njor S
    Prev Med Rep; 2023 Apr; 32():102125. PubMed ID: 36816764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
    PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Participant-Related Risk Factors for False-Positive and False-Negative Fecal Immunochemical Tests in Colorectal Cancer Screening: Systematic Review and Meta-Analysis.
    de Klerk CM; Vendrig LM; Bossuyt PM; Dekker E
    Am J Gastroenterol; 2018 Dec; 113(12):1778-1787. PubMed ID: 30158713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socioeconomic position and participation in colorectal cancer screening.
    Frederiksen BL; Jørgensen T; Brasso K; Holten I; Osler M
    Br J Cancer; 2010 Nov; 103(10):1496-501. PubMed ID: 20959827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland.
    Sarkeala T; Färkkilä M; Anttila A; Hyöty M; Kairaluoma M; Rautio T; Voutilainen M; Helander S; Jäntti M; Lehtinen M; Patrikka L; Malila N; Heinävaara S
    BMJ Open; 2021 Feb; 11(2):e046667. PubMed ID: 33558363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic yield of a risk model versus faecal immunochemical test only: a randomised controlled trial in a colorectal cancer screening programme.
    Kortlever TL; van der Vlugt M; Duijkers FAM; Masclee A; Kraaijenhagen R; Spaander MCW; Lansdorp-Vogelaar I; Bossuyt PM; Dekker E
    Br J Cancer; 2023 Sep; 129(5):791-796. PubMed ID: 37468570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Attendance to an Organized Fecal Immunochemical Test Screening Program on the Risk of Colorectal Cancer: An Observational Cohort Study.
    Baldacchini F; Bucchi L; Giuliani O; Mancini S; Ravaioli A; Vattiato R; Zamagni F; Giorgi Rossi P; Mangone L; Campari C; Sassatelli R; Trande P; Esposito P; Rossi F; Carrozzi G; Triossi O; Fabbri C; Strocchi E; Giovanardi M; Canuti D; Sassoli de Bianchi P; Ferretti S; Falcini F;
    Clin Gastroenterol Hepatol; 2022 Oct; 20(10):2373-2382. PubMed ID: 35144023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Socioeconomic Inequalities in Colorectal Cancer Screening in Korea, 2005-2015: After the Introduction of the National Cancer Screening Program.
    Mai TTX; Lee YY; Suh M; Choi E; Lee EY; Ki M; Cho H; Park B; Jun JK; Kim Y; Oh JK; Choi KS
    Yonsei Med J; 2018 Nov; 59(9):1034-1040. PubMed ID: 30328317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.